De novo cancers in kidney transplant recipients
10.3760/cma.j.issn.0254-1785.2010.05.003
- VernacularTitle:肾移植受者新发恶性肿瘤的生存分析
- Author:
Lixin YU
;
Yun MIAO
;
Wenfeng DENG
;
Yuejun DU
;
Jiang YU
;
Shaojie FU
;
Jian XU
;
Chuanfu DU
;
Yibin WANG
;
Guirong YE
;
Ping HU
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Cancer;
Survival rate
- From:
Chinese Journal of Organ Transplantation
2010;31(5):265-268
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the outcome for kidney transplant recipients who suffered from cancers after transplantation. Methods De novo cancer data in 59 transplant recipients were collected. 6 cases of native renal cell carcinomas, 4 cases of native pelvo-ureteral carcinomas, 14 cases of bladder cancers, 7 cases of prostate cancers, 9 cases of hepatocellular carcinomas, 3 cases of gastric carcinomas, 2 cases of colon cancers, 1 case of pancreatic cancer, 4 cases of breast cancers, 3 cases of cervical cancers, 2 cases of skin cancers, 2 cases of non-small cell lung cancers, 1 case of thyroid cancer and 1 case of post-transplant lymphoproliferative disease. These data were compared with those from 59 patients in general population with the same gender, age and tumor stage. Results Overall incidence rate for de novo malignancy post-transplantation was 1. 9 % (59/3150). Urinary cancers were the most common. Compared to the general population, the overall survival was significantly worsened in transplant recipients (P<0. 01), and 5-year survival rate in transplantation group and control group was 30 % vs 75 0 %. Multivariate analyses demonstrated cancer stage to he a negative risk factor for survival of transplant recipients with de novo cancer, and surgery and functioning graft to be the positive survival predictors. Conclusion Transplant recipients experience worse outcomes than the general population for these cancers. These data suggest that cancers in transplant recipients are more aggressive biologically at the time of diagnosis.
